Dr. Harkins’ research is in biofilm growth of pathogenic fungi.  Biofilms are highly organized communities of microorganisms that are able to adhere to surfaces, proliferate and produce an extracellular matrix for protection.  It is estimated that 70% of all infections of the human body are caused by a biofilm.  The yeast Candida albicans is now the 3rd most common cause of blood stream infections in hospitalized patients.  C. albicans can form efficient biofilms on medical devices that are inserted into the human body, which allow it to gain entry into the bloodstream.  Once a biofilm is formed, it is very difficult to treat since the biofilm can be up to 1000 times more resistant to antimicrobial therapy.

The lab’s focus is in understanding the adherence of the organism to different types of plastics that are used in many of the medical devices, such as catheters.  We have studied the role of certain enzymes that are involved in adherence and mature biofilm growth of clinical isolates of C. albicans and other species.  A goal of the lab is to help determine and define signaling proteins needed by the isolates for biofilm formation, which may ultimately lead to new targets of antimicrobial therapy.

Dr. Harkins also has many collaborative projects with faculty in the Exercise Science Program, Physical Therapy and Chemistry departments including genotyping, measuring cytokines, chemistries, hormones and performing microbiological assays.


Grant Support










Contact Clinical Laboratory Science

Department of Clinical Laboratory Science
College of Health Sciences
Schroeder Complex, 264
P.O. Box 1881
Milwaukee, WI 53201-1881
Phone: (414) 288-7566
FAX: (414) 288-7948